Amelia Cline

Head Of Regulatory Affairs at Pipeline Therapeutics

Amelia Cline currently serves as a Board Member at RICCO GLOBAL COLLECTIVE INC. and as a Principal Consultant at Eight Bridges Consulting. With extensive experience in regulatory affairs, Amelia held the position of Head Of Regulatory Affairs at Contineum Therapeutics from November 2021 to January 2024, and previously served as Director of Regulatory Affairs and Regulatory Affairs Manager at Applied Molecular Transport between July 2017 and November 2021. Prior roles include Sr Regulatory Affairs Specialist and Regulatory Affairs Specialist at Peregrine Pharmaceuticals, as well as Regulatory Affairs and Operations Specialist in consultancy from September 2012 to September 2013. Additional experience includes working as a Document Analyst for the Alzheimer's Disease Cooperative Study (UCSD) and various positions at BioMed IRB, culminating as IRB Administrator.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination, and axonal repair.


Employees

11-50

Links